Targeting Systemic and Gut Microbial Metabolism in ER⁺ Breast Cancer

The authors recent literature concerning the metabolic pathways regulated in ER+ breast tumors by the availability of nutrients and endocrine therapies and summarizes research on how changes in systemic and gut microbial metabolism can affect ER activity and responsiveness to endocrine therapy.